Literature DB >> 33976194

Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation.

Gerdien Mijnheer1, Lisanne Lutter1, Michal Mokry1,2,3, Marlot van der Wal1, Rianne Scholman1, Veerle Fleskens4, Aridaman Pandit1, Weiyang Tao1, Mark Wekking3, Stephin Vervoort1,5, Ceri Roberts4, Alessandra Petrelli1, Janneke G C Peeters1, Marthe Knijff1, Sytze de Roock1, Sebastiaan Vastert1, Leonie S Taams4, Jorg van Loosdregt1,5, Femke van Wijk6.   

Abstract

Treg cells are critical regulators of immune homeostasis, and environment-driven Treg cell differentiation into effector (e)Treg cells is crucial for optimal functioning. However, human Treg cell programming in inflammation is unclear. Here, we combine transcriptional and epigenetic profiling to identify a human eTreg cell signature. Inflammation-derived functional Treg cells have a transcriptional profile characterized by upregulation of both a core Treg cell (FOXP3, CTLA4, TIGIT) and effector program (GITR, BLIMP-1, BATF). We identify a specific human eTreg cell signature that includes the vitamin D receptor (VDR) as a predicted regulator in eTreg cell differentiation. H3K27ac/H3K4me1 occupancy indicates an altered (super-)enhancer landscape, including enrichment of the VDR and BATF binding motifs. The Treg cell profile has striking overlap with tumor-infiltrating Treg cells. Our data demonstrate that human inflammation-derived Treg cells acquire a conserved and specific eTreg cell profile guided by epigenetic changes, and fine-tuned by environment-specific adaptations.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33976194      PMCID: PMC8113485          DOI: 10.1038/s41467-021-22975-7

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  86 in total

1.  Cutting Edge: Dynamic Expression of Id3 Defines the Stepwise Differentiation of Tissue-Resident Regulatory T Cells.

Authors:  Jenna M Sullivan; Barbara Höllbacher; Daniel J Campbell
Journal:  J Immunol       Date:  2018-12-05       Impact factor: 5.422

2.  Interindividual variation in human T regulatory cells.

Authors:  Alessandra Ferraro; Anna Morena D'Alise; Towfique Raj; Natasha Asinovski; Roxanne Phillips; Ayla Ergun; Joseph M Replogle; Angelina Bernier; Lori Laffel; Barbara E Stranger; Philip L De Jager; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-07       Impact factor: 11.205

3.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

4.  Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells.

Authors:  Ellen J Wehrens; Gerdien Mijnheer; Chantal L Duurland; Mark Klein; Jenny Meerding; Jorg van Loosdregt; Wilco de Jager; Birgit Sawitzki; Paul J Coffer; Bas Vastert; Berent J Prakken; Femke van Wijk
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 5.  Homeostatic control of regulatory T cell diversity.

Authors:  Adrian Liston; Daniel H D Gray
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

6.  Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.

Authors:  Mathewos Tessema; Christin M Yingling; Marcie J Grimes; Cynthia L Thomas; Yushi Liu; Shuguang Leng; Nancy Joste; Steven A Belinsky
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

7.  An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.

Authors:  J-S Do; A Visperas; Y O Sanogo; J J Bechtel; N Dvorina; S Kim; E Jang; S A Stohlman; B Shen; R L Fairchild; W M Baldwin; D A A Vignali; B Min
Journal:  Mucosal Immunol       Date:  2015-05-27       Impact factor: 7.313

8.  Human retinoic acid-regulated CD161+ regulatory T cells support wound repair in intestinal mucosa.

Authors:  Giovanni A M Povoleri; Estefania Nova-Lamperti; Cristiano Scottà; Giorgia Fanelli; Yun-Ching Chen; Pablo D Becker; Dominic Boardman; Benedetta Costantini; Marco Romano; Polychronis Pavlidis; Reuben McGregor; Eirini Pantazi; Daniel Chauss; Hong-Wei Sun; Han-Yu Shih; David J Cousins; Nichola Cooper; Nick Powell; Claudia Kemper; Mehdi Pirooznia; Arian Laurence; Shahram Kordasti; Majid Kazemian; Giovanna Lombardi; Behdad Afzali
Journal:  Nat Immunol       Date:  2018-11-05       Impact factor: 25.606

9.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

10.  BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.

Authors:  Rahul Roychoudhuri; Kiyoshi Hirahara; Kambiz Mousavi; David Clever; Christopher A Klebanoff; Michael Bonelli; Giuseppe Sciumè; Hossein Zare; Golnaz Vahedi; Barbara Dema; Zhiya Yu; Hui Liu; Hayato Takahashi; Mahadev Rao; Pawel Muranski; Joseph G Crompton; George Punkosdy; Davide Bedognetti; Ena Wang; Victoria Hoffmann; Juan Rivera; Francesco M Marincola; Atsushi Nakamura; Vittorio Sartorelli; Yuka Kanno; Luca Gattinoni; Akihiko Muto; Kazuhiko Igarashi; John J O'Shea; Nicholas P Restifo
Journal:  Nature       Date:  2013-06-02       Impact factor: 49.962

View more
  9 in total

1.  Classification of human chronic inflammatory skin disease based on single-cell immune profiling.

Authors:  Yale Liu; Hao Wang; Mark Taylor; Christopher Cook; Alejandra Martínez-Berdeja; Jeffrey P North; Paymann Harirchian; Ashley A Hailer; Zijun Zhao; Ruby Ghadially; Roberto R Ricardo-Gonzalez; Roy C Grekin; Theodora M Mauro; Esther Kim; Jaehyuk Choi; Elizabeth Purdom; Raymond J Cho; Jeffrey B Cheng
Journal:  Sci Immunol       Date:  2022-04-15

Review 2.  The Yin and Yang of Targeting KLRG1+ Tregs and Effector Cells.

Authors:  Samantha M Borys; Arup K Bag; Laurent Brossay; Dennis O Adeegbe
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

3.  Chromatin accessibility analysis reveals regulatory dynamics and therapeutic relevance of Vogt-Koyanagi-Harada disease.

Authors:  Wen Shi; Jinguo Ye; Zhuoxing Shi; Caineng Pan; Qikai Zhang; Yuheng Lin; Yuanting Luo; Wenru Su; Yingfeng Zheng; Yizhi Liu
Journal:  Commun Biol       Date:  2022-05-26

Review 4.  Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells.

Authors:  Jingli Lu; Yan Liang; Haiyang Meng; Ailing Zhang; Junjie Zhao; Chengliang Zhang
Journal:  Front Immunol       Date:  2021-08-05       Impact factor: 7.561

Review 5.  Epigenetic Control of Regulatory T Cell Stability and Function: Implications for Translation.

Authors:  Anthony M Joudi; Carla P Reyes Flores; Benjamin D Singer
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 6.  Vitamin D Supplementation in Patients with Juvenile Idiopathic Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jing-Long Huang; Jenn-Haung Lai
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

Review 7.  How does age determine the development of human immune-mediated arthritis?

Authors:  Yannick Degboe; Sebastiaan J Vastert; Berent J Prakken; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2022-08-10       Impact factor: 32.286

Review 8.  Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function.

Authors:  Arielle Raugh; Denise Allard; Maria Bettini
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

9.  Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint.

Authors:  Lisanne Lutter; M Marlot van der Wal; Eelco C Brand; Patrick Maschmeyer; Sebastiaan Vastert; Mir-Farzin Mashreghi; Jorg van Loosdregt; Femke van Wijk
Journal:  Clin Transl Immunology       Date:  2022-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.